Tiny Zymeworks Snags $1.4B+ R&D Deal With Drug Giant Johnson & Johnson Post author:Sam Post published:November 12, 2017 Post category:BioPharma There’s nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace You Might Also Like Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By August 23, 2017 Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M November 15, 2017 Former Allergan Chief Signs On As Special Advisor To Sienna Biopharma February 27, 2017
